St. Jude gets FDA nod for Angio-Seal VIP

Medical device manufacturer St. Jude Medical reported that has received Food and Drug Administration clearance for its Angio-Seal VIP vascular closure device.

The new device, which is approved for both diagnostic and interventional procedures, includes a small anchor, collagen, and a suture, according to the St. Paul, MN-based developer. All components of the Angio-Seal VIP are fully absorbed within 60 to 90 days, so no foreign material permanently remains in the body, the company said.

The device also has received European CE Mark approval, St. Jude said.

By staff writers
March 17, 2006

Related Reading

St. Jude successful with US cardiac ablation, December 21, 2004

Copyright © 2006

Page 1 of 180
Next Page